天價離婚再現!超40億“分手費”,長春高新二股東將大部分股權分給前妻
A股又現天價離婚案。
大部分股權分給前妻
昨日盤後,“藥茅”長春高新公吿稱,於近日收到持股5%以上股東金磊的通知,獲悉金磊與王思勉已通過協議方式辦理了解除婚姻關係手續,並就股份分割事項作出安排。
其中,金磊擬將其持有的公司3001.41萬股股份,約佔公司總股份的7.42%,分割至王思勉名下。
本次權益變動後,金磊持有公司463.16萬股,約佔公司總股本1.14%,不再是公司持股5%以上股東;王思勉成為公司持股5%以上股東。
以公司最新股價133.41元計算,此次擬分割的3001.41萬股股份對應的市值約為40.04億元。

資料顯示,金磊是長春高新的核心骨幹,也是金賽藥業的創始人,金賽藥業是長春高新最重要的子公司,主營生長激素。
長春高新2023年上半年實現營業收入約61.68億元,歸母淨利潤約21.60億元,其中,金賽藥業實現收入51.39億元,實現歸母淨利潤21.97億元,淨利潤反超母公司。
而且據公司2023年半年報,金磊是長春高新第二大股東,持股8.56%。
以往來看,上市公司高管離婚,一般都是自己拿股權大頭,而這次金磊卻把自己持有的大部分股權分給了前妻,自己只留了1.14%的股權,也是很奇怪。
對於A股股民來説,離婚本就是一個敏感詞,因為會擔心持股大股東通過離婚分割股權,再變相減持,長春高新股東這次離婚的將大部分股權分給前妻,更讓人生疑。
此前曾多次減持
值得注意的是,本次離婚的股東金磊此前已經多次減持長春高新股票,算是“減持慣犯”。
回顧來看,2019年,長春高新和金賽藥業進行換股,持有金賽藥業高比例股份的金磊一躍成為長春高新第二大股東,持股比例11.51%,對應股份4658.34萬股。
2020年四季度-2021年二季度,長春高新股價處於高位,金磊頻繁套現,將持股比例降至8.56%。

對於此次離婚的影響,長春高新迴應稱,分割行為對金磊作為金賽藥業總經理、主持金賽藥業的經營管理工作沒有任何影響。
同時,減持公吿稱,自本次因解除婚姻關係導致長春高新股東權益變化發生後,金磊、王思勉仍將作為一致行動人,在完成股份非交易過户相關手續的12個月內,不以任何方式減持各自持有的長春高新股票,包括承諾期間因公司股份發生資本公積轉增股本、派送股票紅利、配股、增發等產生的股份。
近期,醫藥的投資者可謂是有點糟心,昨日市場反彈,醫藥股也跟隨上升,但龍頭藥明生物又掉鏈子,被質疑新籤項目數再一個月內大變臉。
現在,又出了長春高新核心骨幹離婚這事,不知道,醫藥股會如何表現。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.